Results 241 to 250 of about 44,337 (296)
Food Biomacromolecules, EarlyView.Abstract As one of the most important components of foods, animal meat provides a lot of protein, fat, and energy for humans. However, nutrition and health of animals directly affect the healthiness of human, especially antibiotic residues in animals induced by abuse of antibiotics.
Zichao Wang +8 more
wiley +1 more source
Head &Neck, EarlyView.ABSTRACT Background The association of chloride intracellular channel 2 (CLIC2) with tumors has remained unclear. However, recently, CLIC2 was found to exhibit antitumor properties in some tumors. In this study, we aimed to evaluate the clinical relevance of CLIC2 expression in head and neck squamous cell carcinoma (HNSCC) to determine whether it ...
Yuki Hosokawa +9 more
wiley +1 more source
A new challenging dilemma to prevent major cardiovascular events in patients with chronic venous disorders. [PDF]
J Vasc Surg Venous Lymphat DisordZamboni P.
europepmc +1 more source
Targeted volume imaging reveals early vascular interactions of Lyme disease pathogen in skin. [PDF]
Nat CommunStrnad M +5 more
europepmc +1 more source
Bilateral renal lymphangiectasia mimicking renal cystic disease and literature review. [PDF]
BJR Case RepTacyildiz C, Yergin Tacyildiz S.
europepmc +1 more source
Ibrain, EarlyView.In this review, agents such baicalein, troxerutin, epigallocatechin gallate, quercetin, melatonin, valproic acid, lithium, neurosteroid progesterone, as well as minocycline have been implicated as neuroprotective agents for irradiation‐induced neurological deficits. Also, agents such as glucocorticoids, methylphenidate, vitamin E, bisdemethoxycurcumin,
Seidu A. Richard +2 more
wiley +1 more source
An Exceptionally Rare Ovarian Lymphangioma Mimicking a Dermoid Cyst Recurrence: A Case Report. [PDF]
CureusHemdan M, Arora R, Ma W.
europepmc +1 more source
International Journal of Cancer, EarlyView.What's New? The combination of ipilimumab and nivolumab as a first‐line treatment for advanced renal cell carcinoma has demonstrated durable response and tolerability in clinical trials. However, inclusion criteria for clinical studies are restrictive, and patients in the real‐world setting tend to have more comorbidities.
Hendrik Dinkel +21 more
wiley +1 more source
HIF2A as a prognostic and clinical therapeutic target in ovarian clear cell carcinoma
International Journal of Cancer, EarlyView.What's New? Ovarian clear cell carcinoma is highly associated with hypoxia. Hypoxia‐inducible factor 2A (HIF2A) is a key regulator of hypoxic responses, but its role in ovarian clear cell carcinoma remains unclear. This study demonstrated the unfavorable prognostic significance of HIF2A expression in ovarian clear cell carcinoma.
Mengxin Jiang +15 more
wiley +1 more source